Q2 FY2026 · ended Jun 30, 2026 · Revenue $2.18M, +16.7% YoY · Filed Aug 14, 2026
INVO Fertility, Inc. (IVF) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $2.2 million and net income of $888,740. Free cash flow was -$1.1 million. As of Jun 30, 2026 it held $3.7 million in cash and investments and $3.9 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IVF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1417926
- Former names
- NAYA Biosciences, Inc. (until Apr 14, 2025); INVO Bioscience, Inc. (until Oct 15, 2024); EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (until Jan 5, 2009)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $2.2M | $2.0M | $1.6M | $1.8M | $1.9M |
| Operating income | -$1.3M | -$1.6M | -$1.4M | -$1.6M | -$3.0M |
| Net income | $888,740 | -$5.5M | $1.1M | -$3.4M | -$3.6M |
| Diluted EPS | $0.35 | -$3.38 | -$0.05 | -$39.40 | -$364.23 |
| Operating cash flow | -$1.1M | -$1.9M | $25,207 | -$1.8M | -$1.7M |
| Free cash flow | -$1.1M | — | $13,384 | -$1.8M | -$1.7M |
| Total assets | $25.8M | $24.7M | $20.2M | $18.8M | $19.3M |
| Total liabilities | $9.3M | $9.6M | $13.0M | $13.0M | $16.2M |
| Stockholders' equity | $16.5M | $15.0M | $7.2M | $5.8M | -$7.2M |
| Cash and investments | $3.7M | $4.9M | $2.1M | $355,891 | $549,181 |
| Total debt | $3.9M | $4.0M | $3.4M | $4.2M | $7.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 4, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 28, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
Jul 24, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 25, 2026 | Jun 23, 2026 |
All 596 INVO Fertility, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.